These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Solubilization of immune complexes and inhibition of immune precipitation in SLE sera. Balestrieri G; Pagani D; Tincani A J Clin Lab Immunol; 1983 Nov; 12(3):147-50. PubMed ID: 6663608 [TBL] [Abstract][Full Text] [Related]
7. The effect of sera of patients with systemic lupus erythematosus on artificial immune complexes. Bányai A; Szabó G; Csongor J; Sonkoly I; Szegedi G Acta Med Hung; 1985; 42(1-2):51-7. PubMed ID: 4034337 [TBL] [Abstract][Full Text] [Related]
8. Complement activation and impaired capacity to solubilize immune complexes or to prevent their formation in essential mixed cryoglobulinemia. Corvetta A; Spaeth PJ; Ghirelli PA; Orecchioni F; Buetler R; Montroni M; Nydegger UE Diagn Immunol; 1983; 1(4):315-23. PubMed ID: 6333960 [TBL] [Abstract][Full Text] [Related]
9. Complement components, C1 activation and disease activity in SLE. Sturfelt G; Sjöholm AG; Svensson B Int Arch Allergy Appl Immunol; 1983; 70(1):12-8. PubMed ID: 6293980 [TBL] [Abstract][Full Text] [Related]
10. A simple enzyme immunoassay for measurement of immune complex solubilization utilizing preformed peroxidase-antiperoxidase complexes. Johansson I; Sturfelt G; Truedsson L J Immunoassay; 1994 Nov; 15(4):393-409. PubMed ID: 7836544 [TBL] [Abstract][Full Text] [Related]
11. Decreased capacity to solubilize immune complexes in sera from patients with systemic lupus erythematosus. Aguado MT; Perrin LH; Miescher PA; Lambert PH Arthritis Rheum; 1981 Oct; 24(10):1225-9. PubMed ID: 7306225 [TBL] [Abstract][Full Text] [Related]